FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894961387> ?p ?o ?g. }

• W2894961387 endingPage "266" @default.
• W2894961387 startingPage "263" @default.
• W2894961387 abstract "Abstract Context: In acute lymphoblastic leukemia (ALL), the most important prognostic factors are age, leukocyte count at presentation, immunophenotype, and cytogenetic abnormalities. The cytogenetic abnormalities are associated with distinct immunologic phenotypes of ALL and characteristic outcomes. Aims: The present study was primarily aimed at analyzing the impact of cytogenetics on postinduction responses and event-free survival (EFS) in pediatric patients with ALL. The secondary objective was to study the overall survival (OS). Subjects and Methods: A total of 240 patients with age <18 years and diagnosed with ALL between January 2011 and June 2016 were retrospectively analyzed. Cytogenetics was evaluated with conventional karyotyping or reverse transcriptase polymerase chain reaction. Based on cytogenetic abnormalities, the patients were grouped into five categories, and the outcomes were analyzed. Results: Of the 240 patients, 125 (52%) patients had evaluable cytogenetics. Of these, 77 (61.6%) patients had normal cytogenetics, 19 (15.2%) had t(9;22) translocation, 10 (8%) had unfavorable cytogenetics which included t(9;11), hypodiploidy, and complex karyotype, 10 (8%) had favorable cytogenetics which included t(12;21), t(1;19), and high hyperdiploidy, 9 (7.2%) had miscellaneous cytogenetics. Seventy-one percent of patients were treated with MCP 841 protocol, while 29% of patients received BFM-ALL 95 protocol. The 3-year EFS and OS of the entire group were 52% and 58%, respectively. On univariate analysis, EFS and OS were significantly lower in t(9;22) compared to normal cytogenetics (P = 0.033 and P = 0.0253, respectively) and were not significant for other subgroups compared to normal cytogenetics. On multivariate analysis, EFS was significantly lower for t(9;22) and unfavorable subgroups. Conclusions: Cytogenetics plays an important role in the molecular characterization of ALL defining the prognostic subgroups. Patients with unfavorable cytogenetics and with t(9;22) have poorer outcomes." @default.
• W2894961387 created "2018-10-12" @default.
• W2894961387 creator A5005767210 @default.
• W2894961387 creator A5006424747 @default.
• W2894961387 creator A5035199182 @default.
• W2894961387 creator A5051930794 @default.
• W2894961387 creator A5067415896 @default.
• W2894961387 creator A5084594068 @default.
• W2894961387 date "2018-10-01" @default.
• W2894961387 modified "2023-10-12" @default.
• W2894961387 title "Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia" @default.
• W2894961387 cites W1558704041 @default.
• W2894961387 cites W1913546741 @default.
• W2894961387 cites W1936525467 @default.
• W2894961387 cites W2007437787 @default.
• W2894961387 cites W2010079078 @default.
• W2894961387 cites W2010641860 @default.
• W2894961387 cites W2026996664 @default.
• W2894961387 cites W2041554619 @default.
• W2894961387 cites W2042138663 @default.
• W2894961387 cites W2052963155 @default.
• W2894961387 cites W2053908817 @default.
• W2894961387 cites W2059999488 @default.
• W2894961387 cites W2063898537 @default.
• W2894961387 cites W2068936243 @default.
• W2894961387 cites W2074181164 @default.
• W2894961387 cites W2078307731 @default.
• W2894961387 cites W2089034663 @default.
• W2894961387 cites W2134118606 @default.
• W2894961387 cites W2287494996 @default.
• W2894961387 cites W2339658711 @default.
• W2894961387 cites W2412039589 @default.
• W2894961387 doi "https://doi.org/10.4103/sajc.sajc_13_18" @default.
• W2894961387 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6190389" @default.
• W2894961387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30430098" @default.
• W2894961387 hasPublicationYear "2018" @default.
• W2894961387 type Work @default.
• W2894961387 sameAs 2894961387 @default.
• W2894961387 citedByCount "9" @default.
• W2894961387 countsByYear W28949613872018 @default.
• W2894961387 countsByYear W28949613872019 @default.
• W2894961387 countsByYear W28949613872020 @default.
• W2894961387 countsByYear W28949613872021 @default.
• W2894961387 countsByYear W28949613872022 @default.
• W2894961387 countsByYear W28949613872023 @default.
• W2894961387 crossrefType "journal-article" @default.
• W2894961387 hasAuthorship W2894961387A5005767210 @default.
• W2894961387 hasAuthorship W2894961387A5006424747 @default.
• W2894961387 hasAuthorship W2894961387A5035199182 @default.
• W2894961387 hasAuthorship W2894961387A5051930794 @default.
• W2894961387 hasAuthorship W2894961387A5067415896 @default.
• W2894961387 hasAuthorship W2894961387A5084594068 @default.
• W2894961387 hasBestOaLocation W28949613871 @default.
• W2894961387 hasConcept C104317684 @default.
• W2894961387 hasConcept C126322002 @default.
• W2894961387 hasConcept C143998085 @default.
• W2894961387 hasConcept C144301174 @default.
• W2894961387 hasConcept C151730666 @default.
• W2894961387 hasConcept C174475383 @default.
• W2894961387 hasConcept C196166836 @default.
• W2894961387 hasConcept C203014093 @default.
• W2894961387 hasConcept C2778461978 @default.
• W2894961387 hasConcept C2779343474 @default.
• W2894961387 hasConcept C30481170 @default.
• W2894961387 hasConcept C38180746 @default.
• W2894961387 hasConcept C53226629 @default.
• W2894961387 hasConcept C54355233 @default.
• W2894961387 hasConcept C553184892 @default.
• W2894961387 hasConcept C71924100 @default.
• W2894961387 hasConcept C86803240 @default.
• W2894961387 hasConceptScore W2894961387C104317684 @default.
• W2894961387 hasConceptScore W2894961387C126322002 @default.
• W2894961387 hasConceptScore W2894961387C143998085 @default.
• W2894961387 hasConceptScore W2894961387C144301174 @default.
• W2894961387 hasConceptScore W2894961387C151730666 @default.
• W2894961387 hasConceptScore W2894961387C174475383 @default.
• W2894961387 hasConceptScore W2894961387C196166836 @default.
• W2894961387 hasConceptScore W2894961387C203014093 @default.
• W2894961387 hasConceptScore W2894961387C2778461978 @default.
• W2894961387 hasConceptScore W2894961387C2779343474 @default.
• W2894961387 hasConceptScore W2894961387C30481170 @default.
• W2894961387 hasConceptScore W2894961387C38180746 @default.
• W2894961387 hasConceptScore W2894961387C53226629 @default.
• W2894961387 hasConceptScore W2894961387C54355233 @default.
• W2894961387 hasConceptScore W2894961387C553184892 @default.
• W2894961387 hasConceptScore W2894961387C71924100 @default.
• W2894961387 hasConceptScore W2894961387C86803240 @default.
• W2894961387 hasIssue "04" @default.
• W2894961387 hasLocation W28949613871 @default.
• W2894961387 hasLocation W28949613872 @default.
• W2894961387 hasLocation W28949613873 @default.
• W2894961387 hasLocation W28949613874 @default.
• W2894961387 hasLocation W28949613875 @default.
• W2894961387 hasOpenAccess W2894961387 @default.
• W2894961387 hasPrimaryLocation W28949613871 @default.
• W2894961387 hasRelatedWork W1902611225 @default.
• W2894961387 hasRelatedWork W2040062056 @default.
• W2894961387 hasRelatedWork W2058643615 @default.

• next